Clinical Trial

Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
To assess the long-term safety and efficacy of the BAROSTIM NEO System in trial (NCT01471834) participants.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2011-11-10; most recent amendment 2025-07-10.
Status change: Not Yet Recruiting → Active, Not Recruiting 2012-10-29
Trial Details
NCT Number NCT01471834
Lead Sponsor CVRx, Inc.
Conditions High Blood Pressure
Enrollment 40 participants
Start Date 2011-06
Primary Completion 2012-05 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-07-15